Items where Subject is "diseases & disorders > cancer > cancer types > lymphoma"

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Authors | Item Type
Jump to: B | D | G | L | O | S | W
Number of items at this level: 18.

B

Burgess, D. J., Doles, J., Zender, L., Xue, W., Ma, B., McCombie, W. R., Hannon, G. J., Lowe, S. W., Hemann, M. T. (2008) Topoisomerase levels determine chemotherapy response in vitro and in vivo. Proc Natl Acad Sci U S A, 105 (25). pp. 9053-9058.

D

Dickins, R. A., McJunkin, K., Hernando, E., Premsrirut, P. K., Krizhanovsky, V., Burgess, D. J., Kim, S. Y., Cordon-Cardo, C., Zender, L., Hannon, G. J., Lowe, S. W. (2007) Tissue-specific and reversible RNA interference in transgenic mice. Nat Genet, 39 (7). 914 - 921. ISSN 1061-4036 (Print)

G

Galteland, E., Sivertsen, E. A., Svendsrud, D. H., Smedshammer, L., Kresse, S. H., Meza-Zepeda, L. A., Myklebost, O., Suo, Z., Mu, D., DeAngelis, P. M., Stokke, T. (2005) Translocation t(14;18) and gain of chromosome 18/BCL2: effects on BCL2 expression and apoptosis in B-cell non-Hodgkin's lymphomas. Leukemia, 19 (12). pp. 2313-2323. ISSN 0887-6924

L

Li, Z. R., Van Calcar, S., Qu, C. X., Cavenee, W. K., Zhang, M. Q., Ren, B. (2003) A global transcriptional regulatory role for c-Myc in Burkitt's lymphoma cells. Proceedings of the National Academy of Sciences of the United States of America, 100 (14). pp. 8164-8169. ISSN 0027-8424

Lindemann, R. K., Newbold, A., Whitecross, K. F., Cluse, L. A., Frew, A. J., Ellis, L., Williams, S., Wiegmans, A. P., Dear, A. E., Scott, C. L., Pellegrini, M., Wei, A., Richon, V. M., Marks, P. A., Lowe, S. W., Smyth, M. J., Johnstone, R. W. (2007) Analysis of the apoptotic and therapeutic activities of histone deacetylase inhibitors by using a mouse model of B cell lymphoma. Proc Natl Acad Sci U S A, 104 (19). pp. 8071-6. ISSN 0027-8424

Lowe, S. W., Schmitt, C., Fridman, J., Rosenthal, C. (2001) Genetics of drug sensitivity and resistance in a mouse lymphoma model. Clinical Cancer Research, 7 (11). 3828S-3829S. ISSN 1078-0432

O

Olive, V., Bennett, M. J., Walker, J. C., Ma, C., Jiang, I., Cordon-Cardo, C., Li, Q. J., Lowe, S. W., Hannon, G. J., He, L. (2009) miR-19 is a key oncogenic component of mir-17-92. Genes & Development, 23 (24). pp. 2839-2849. ISSN 0890-9369

S

Schmitt, C. A., Fridman, J., Lowe, S. W. (2000) Molecular genetics of drug sensitivity and resistance in a mouse lymphoma model. British Journal of Cancer, 83. p. 4. ISSN 0007-0920

Schmitt, C. A., Helmrich, A., Lee, S., Dorken, B., Lowe, S. W., Schrock, E. (2003) Impact of recurrent cytogenetic abnormalities in INK4a/ARF defective primary lymphomas on chemosensitivity in vivo. Blood, 102 (11). 68A-69A. ISSN 0006-4971

Schmitt, C. A., Lowe, S. W. (2001) Bcl-2 mediates chemoresistance in matched pairs of primary E mu-myc lymphomas in vivo. Blood Cells Molecules and Diseases, 27 (1). pp. 206-216. ISSN 1079-9796

Schmitt, C. A., McCurrach, M. E., de Stanchina, E., Wallace-Brodeur, R. R., Lowe, S. W. (1999) INK4a/ARF mutations accelerate lymphomagenesis and promote chemoresistance by disabling p53. Genes and Development, 13 (20). pp. 2670-7. ISSN 0890-9369 (Print)

Schmitt, C. A., Wallace-Brodeur, R. R., Rosenthal, C. T., McCurrach, M. E., Lowe, S. W. (2000) DNA damage responses and chemosensitivity in the E mu-myc mouse lymphoma model. Cold Spring Harbor Symposia on Quantitative Biology, 65. pp. 499-510. ISSN 0091-7451

Schmitt, C. A., Yang, M., Fridman, J. S., Baranov, E., Hoffman, R. M., Lowe, S. W. (2001) Myc-driven lymphomas respond with both apoptosis and senescence to anticancer treatment in vivo. Blood, 98 (11). 172B-172B. ISSN 0006-4971

Scuoppo, C. (2011) Architectural Models of Tumor Suppression in Lymphoma. PhD thesis, Cold Spring Harbor Laboratory.

Sivertsen, E. A., Galteland, E., Mu, D., Holte, H., Meza-Zepeda, L., Myklebost, O., Patzke, S., Smeland, E. B., Stokke, T. (2006) Gain of chromosome 6p is an infrequent cause of increased PIM1 expression in B-cell non-Hodgkin's lymphomas [13]. Leukemia, 20 (3). pp. 539-542. ISSN 08876924

W

Wendel, H. G., Lowe, S. W. (2004) Reversing drug resistance in vivo. Cell Cycle, 3 (7). pp. 847-9. ISSN 1551-4005 (Electronic)

Wendel, H. G., Malina, A., Zhao, Z., Zender, L., Kogan, S. C., Cordon-Cardo, C., Pelletier, J., Lowe, S. W. (2006) Determinants of sensitivity and resistance to rapamycin-chemotherapy drug combinations in vivo. Cancer Res, 66 (15). pp. 7639-46. ISSN 0008-5472 (Print)

Wendel, H. G., Silva, R. L., Malina, A., Mills, J. R., Zhu, H., Ueda, T., Watanabe-Fukunaga, R., Fukunaga, R., Teruya-Feldstein, J., Pelletier, J., Lowe, S. W. (2007) Dissecting eIF4E action in tumorigenesis. Genes Dev, 21 (24). pp. 3232-7.

This list was generated on Sun Oct 22 20:37:17 2017 EDT.
CSHL HomeAbout CSHLResearchEducationNews & FeaturesCampus & Public EventsCareersGiving